A Correction to this paper has been published: https://doi.org/10.1007/s00467-020-04892-x

An Erratum to this paper has been published: https://doi.org/10.1007/s12508-020-00286-4

An Erratum to this paper has been published: https://doi.org/10.1007/s10343-020-00526-2

A Correction to this paper has been published: https://doi.org/10.1007/s00006-020-01074-8

A Correction to this paper has been published: https://doi.org/10.1007/s10704-020-00492-w

Int J Obes (Lond). 2020 Oct;44(10):2011–2022. 10.1038/s41366-020-0644-1. https://pubmed.ncbi.nlm.nih.gov/32713944/

Edgar Fernandes,1 Fabio Donati,1 François Patthey,1 Srdjan Stavrić,2 Željko Šljivančanin,2,3 and Harald Brune1,* 1Institute of Physics, Ecole Polytechnique Fédérale de Lausanne, Station 3, CH-1015 Lausanne, Switzerland 2Vinča Institute of Nuclear Sciences (020), University of Belgrade, P.O.Box 522, 11001 Belgrade, Serbia 3The Science Program, Texas A&M University at Qatar, Doha, Qatar (Received...

We determined the PCR ribotypes and antimicrobial susceptibility patterns of 508 toxigenic Clostridium difficile isolates collected between 2011 and 2013 from 32 U.S. hospitals. Of the 29 PCR ribotypes identified, the 027 strain type was the most common (28.1%), although the rates varied by geographic region. Ribotype 014/020 isolates appear to be emerging. Clindamycin and moxifloxacin resistan...